share_log

和黄医药(00013.HK)拟7月31日举行董事会会议批准中期业绩

Hutchmed (China) (00013.HK) plans to hold a board of directors meeting on July 31 to approve its mid-term performance.

Gelonghui Finance ·  Jun 26 04:42

Hutchmed (China) (00013.HK) announced on June 26th that the company will hold a board meeting on Wednesday, July 31st, 2024 to approve the mid-term performance of the company and its subsidiaries for the six months ending on June 30th, 2024 (including) and release it at 7:00 pm that day (Hong Kong time).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment